Showcased end-to-end, customized manufacturing capabilities covering vaccines, gene and immune thera...

Hilleman Laboratories holds its Board meeting in Korea to deepen collaboration with SK bioscienceVis...

Candidate designed to protect against COVID-19 variants and broader SarbecovirusesPhase 1/2 study to...

Administration begins for infants under 12 months, expected to provide protection throughout the RSV...

Vaccination available for all age groups from October as travel and family gatherings increase befor...

Approximately 800 children aged 12 months to 12 years in Korea and abroad, aiming for completion by ...

Nationwide symposiums over two months enhanced RSV awareness and shared prevention strategies.Sessio...

SK Group Chairman Tae-won Chey met with Bill Gates, Chairman of TerraPower, to further strengthen...

Company holds a dedicated meeting with Gates Foundation executives during Bill Gates’ visit to Korea...

Company runs promotional booth on RSV disease awareness during the event at COEX, Seoul.Parents of y...

Company establishes integrated ESG management system by consolidating ESG information from its subsi...

Green light for Phase 1 and 3 trials paves the way for Chinese market entryGlobal Phase 3 trial unde...